Patel Sujal M
Known title: CEO, President, and SecretaryCIK: 0001378830
Patel Sujal M's purchase track record
How the stock did after each of Patel Sujal M's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
8
of 8 since November 30, 2021
Stock higher 6 months later
13%
3 months: 25%
Median 6-month return
-26.9%
3 months: -9.9%
Beat the S&P 500
13%
median -28.8% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/4/2026 | NAUT | $65K | -1.5% | -63.3% | +11.6% |
| 9/5/2025 | NAUT | $136K | +207.1% | +273.7% | +4.0% |
| 3/19/2025 | NAUT | $77K | -26.3% | -24.9% | +16.3% |
| 3/5/2024 | NAUT | $141K | -1.1% | -2.7% | +8.9% |
| 8/5/2022 | NAUT | $146K | -29.3% | -28.9% | -0.2% |
| 5/9/2022 | NAUT | $198K | -18.3% | -40.7% | -4.6% |
| 3/3/2022 | NAUT | $180K | +8.0% | -38.0% | -9.1% |
| 11/30/2021 | NAUT | $1.18M | -19.4% | -24.5% | -9.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| NAUT | ▲ Buy | Open Market | 25,000 | $65K | 3/4/2026 | View on chart |
| NAUT | ▲ Buy | Open Market | 83,500 | $57K | 9/8/2025 | View on chart |
| NAUT | ▲ Buy | Open Market | 116,500 | $79K | 9/5/2025 | View on chart |
| NAUT | ▲ Buy | Open Market | 23,933 | $24K | 3/20/2025 | View on chart |
| NAUT | ▲ Buy | Open Market | 53,300 | $53K | 3/19/2025 | View on chart |
| NAUT | ▲ Buy | Open Market | 12,044 | $34K | 3/11/2024 | View on chart |
| NAUT | ▲ Buy | Open Market | 2,430 | $7K | 3/8/2024 | View on chart |
| NAUT | ▲ Buy | Open Market | 18,854 | $54K | 3/7/2024 | View on chart |
| NAUT | ▲ Buy | Open Market | 9,267 | $25K | 3/6/2024 | View on chart |
| NAUT | ▲ Buy | Open Market | 7,405 | $20K | 3/5/2024 | View on chart |
| NAUT | ▲ Buy | Open Market | 8,346 | $24K | 8/8/2022 | View on chart |
| NAUT | ▲ Buy | Open Market | 41,654 | $122K | 8/5/2022 | View on chart |
| NAUT | ▲ Buy | Open Market | 50,000 | $198K | 5/9/2022 | View on chart |
| NAUT | ▲ Buy | Option Exercise | 100 | $1K | 3/4/2022 | View on chart |
| NAUT | ▲ Buy | Open Market | 50,000 | $180K | 3/3/2022 | View on chart |
| NAUT | ▲ Buy | Open Market | 88,022 | $416K | 12/1/2021 | View on chart |
| NAUT | ▲ Buy | Open Market | 161,978 | $765K | 11/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Roth Capital initiates coverage on NAUT with $3.50 target
Roth Capital began tracking Nautilus Biotechnology with a Buy rating and a price target of $3.50. This new analyst note adds to the current consensus, where the average target from two analysts is $4.00. The stock is currently trading within its 52-week range of $0.72 to $4.31.
Roth Capital initiates coverage on NAUT with $3.50 target. Roth Capital began tracking Nautilus Biotechnology with a Buy rating and a price target of $3.50. This new analyst note adds to the current consensus, where the average target from two analysts is $4.00. The stock is currently trading within its 52-week range of $0.72 to $4.31.